Similar rates of percutaneous coronary intervention (PCI), coronary artery bypass grafting (CABG), and medical therapy for coronary artery disease (CAD) were found in patients with and without end-stage renal disease (ESRD).
ESRD alone does not influence the choice of therapy for CAD, researchers concluded in a presentation at the American College of Cardiology’s 68th Annual Scientific Session & Expo, held March 16-18 in New Orleans, Louisiana, and published in the Journal of the American College of Cardiology.1
Patients with ESRD, however, had significantly higher 30-day and 6-month readmission rates and longer hospital length of stay (LOS) than patients without ESRD.
In a retrospective study of 9027 patients who underwent cardiac catheterization from 2005 to 2015, 127 (1.4%) had ESRD and were on hemodialysis. Patients with and without ESRD showed no significant difference in the rates of PCI (33.3% vs 33.6%, respectively), CABG (35.9% and 30.2%, respectively), and medical therapy (30.8% and 36.2%, respectively) for CAD, Preetham Reddy Muskula, MBBS, and colleagues at Saint Louis University in Missouri, reported.
The 30-day and 6-month readmission rates were 17.3% and 35.4%, respectively, in the ESRD group compared with 9.6% and 16.9%, respectively, in the non-ESRD group. The average LOS was 4.5% in the ESRD group compared with 2.8 days in the non-ESRD group.
The ESRD and non-ESRD groups did not differ significantly with respect to age (59.7 vs 59.3, respectively), sex ratio (66.9% vs 63% men, respectively), and percentage of patients with obstructive CAD (61.4% vs 62.3%, respectively) and hypertension (35% vs 34%, respectively). The ESRD group had a significantly higher percentage of patients with diabetes vs the non-ESRD group (44.9% vs 18%, respectively).
Muskula PR, Alkhawam H, Ampadu J, Popp M, Helmy T. Analysis of treatment strategies and short-term outcomes for coronary artery disease in end-stage renal disease (ESRD) compared to non-ESRD patients following cardiac catheterization. Presented at: American College of Cardiology’s 68th Annual Scientific Session & Expo; March 16-18, 2019; New Orleans, LA. Abstract 1275-394.